WELCOME BACK!

On this week’s edition of The Deal Room:

• Updates: Happy Holidays & prep for the January Deal Call

• Deals: Repurpose, Audiomob, and JIBB

• What We Read: Auto Merger, Founders Fund, Phoenix Tailings, and FINTOP

Updates for this Week: 01.02.24 🗓️

I hope everyone has some fun over the holidays. Now, let’s start the year off right!

We will be picking back up in the New Year with our January Deal Call! Quick Reminder - We host monthly Deal Calls on the first Tuesday of every month. Mark your calendars for the January call now. I look forward to seeing you then.

If you have any friends or mentors in the VC community that you think would be a good fit, please consider inviting them to apply.

Reminder - Partner Track’s Student Ambassador Program officially kicked off in November. Initial participants include students from our partnering universities MIT, UC Berkeley, & Yale. Thank you to the network members who have introduced us to their alma maters. We would love to see a few other universities join in as well, so feel free to spread the word. Also, anyone who is interested in speaking/meeting the cohort of students, please respond to this email or reach out to Jonathan@PartnerTrackVC.

As always, thank you for being a part of Partner Track! We hope that you enjoy The Deal Room.

Reply to this email if you are interested in any of the following deals.

Repurpose
Series-A | Compostable Products

Repurpose is the market leader in compostable products for the home at affordable prices. On a mission to replace plastic disposable products with stylish, sturdy, and compostable alternatives, their products are available nationwide in over 12,000 stores, including Costco, Kroger, Albertsons, Whole Foods, Wegmans, Wakefern, Amazon, and others. They hold the #1 brand of eco-disposable tableware in the category and have recently landed within the top 10 of all tableware and trash bag brands globally. They’ve already replaced over 540 million pieces of plastic!

• Led by a female founder, the brand is well positioned to capture the 28.7B US market (over $100B globally).

• As of December, they were on track to generate $25M for FY 2024.

• Raising a $10M Series-B round ($8.8m committed).

• Current investors include The 22 Fund, Elysian Park VC, PGA Ventures, Pritzker Group VC, and SWAT Equity Partners.

Audiomob
Seed Stage | AdTech | In-game Ads

Audiomob aims to revolutionize the monetization of mobile games by integrating audio-only ads into the gaming process, thus enhancing player retention and allowing game developers to better monetize their games. The company is black-owned, and both founders were included in Forbes’ 30 Under 30 list. Founder and CEO, Christian Facey, was a senior strategist at Google and a marketing science partner at Facebook. Building on their core ad technology, the company has built an internal GenAI which optimizes ad placement, boosts performance metrics, and generates high quality audio creatives from scratch. Their recent partnership with Samsung is expected to generate $100M+ over the next 5 years.

• $10m in topline revenue 2024

• Raising a $30M Series B

• Current investors include Lightspeed, Samsung, Makers Fund, and Supernode Global.

JIBB
Seed Stage | B2B SaaS | AI

JIBB leverages Computer Vision and GenAI to connect offline and online brainstorming collaborations to (1) Enhance productivity and safeguard an enterprise’s intellectual property during any ideation and brainstorming sessions, and (2) Optimize collaboration workflow with real-time insights, automated document generation, and direct translation of thoughts into action. integrated with other tools, too. JIBB has 22 enterprise clients and established GTM partnerships with Cisco, HP, and Lucid Software.

• $1M ARR, on track to $5M ARR by 2025.

• Raising a $1.5m seed round, with $700K Committed.

• Slide Deck

Vasa Therapeutics
Seed Stage | Pharma | Novel Therapeutics

Vasa Therapeutics - Novel therapeutics for unmet medical needs in cardiovascular medicine. The company currently has two drugs in Phase 1 clinical trials. During this phase, the company aims to explore licensing opportunities and finalize strategic partnerships with complementary drug manufacturers and Big Pharma.

• Raising $20M Seed round to complete clinical trials for their two leading drugs

• Previously raised $13M 

  Taser Deck .pdf782.20 KB • PDF File Download